文献速递临床试验与 GCP

富血小板血浆对比皮质类固醇注射治疗扳机指:前瞻性随机三盲安慰剂对照试验方案

Platelet-rich plasma versus corticosteroid injection for treatment of trigger finger: study protocol for a prospective randomized triple-blind placebo-controlled trial.
PubMed 文献 · Trials · 2020-11-27

扳机指因腱鞘与屈肌腱失衡所致,常首选局部皮质类固醇注射,但部分患者仍需手术且可能发生不良事件。富血小板血浆(PRP)在其他肌腱病变中已显示安全且可减轻症状,但对扳机指的效果尚未研究。本单中心三盲三臂1:1:1非劣效性随机对照试验旨在比较PRP与皮质类固醇注射治疗扳机指的非劣效性,并评估PRP对比安慰剂的安全性和有效性。

要点

  • PRP对比皮质类固醇治疗扳机指的非劣效性尚待本试验验证。
  • 试验设PRP、皮质类固醇与生理盐水三臂,患者、研究者及结果评估者均设盲。
  • 主要结局为患者 rated 腕部评价(PRWE)与症状缓解。

核心结论

  • PRP治疗扳机指是否非劣效于皮质类固醇注射尚待本试验结果验证。
  • PRP对比安慰剂的安全性和有效性将作为次要结局评估。

研究设计与样本

  • 单中心、三盲、三臂1:1:1非劣效性随机对照试验。
  • 受试者为具有扳机指临床症状的患者,随机分配至PRP、皮质类固醇或生理盐水注射组。
  • 患者、研究者和结果评估者均设盲。

主要发现

  • PRP已在不同肌腱病变(如DeQuervain病)中显示安全且可减轻症状。
  • PRP对扳机指的效果此前尚未被研究。

关键数值与推荐

  • 主要结局为患者 rated 腕部评价(Patient-Rated Wrist Evaluation)和症状缓解。
  • 次要结局包括Quick-DASH、疼痛、握力、手指主动活动度和并发症。

临床怎么用

  • 本试验结果将提示PRP是否适用于扳机指的治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Trigger finger is a common hand disorder that limits finger range of motion and causes pain and snapping of the affected finger. Trigger finger is caused by an imbalance of the tendon sheath and the flexor tendon. The initial treatment is generally a local corticosteroid injection around the first annular (A1) pulley. However, it is not unusual that surgical release of the A1 pulley is required. Moreover, adverse events after local corticosteroid injection or operative treatment may occur. Platelet-rich plasma (PRP) has been shown to be safe and to reduce symptoms in different tendon pathologies, such as DeQuervain's disease. However, the effects of PRP on trigger finger have not been studied. The aim of this single-center triple-blind randomized controlled trial is to study whether PRP is non-inferior to corticosteroid injection in treating trigger finger. The secondary outcome is to assess the safety and efficacy of PRP in comparison to placebo. METHODS: The trial is designed as a randomized, controlled, patient-, investigator-, and outcome assessor-blinded, single-center, three-armed 1:1:1 non-inferiority trial. The patients with clinical symptoms of trigger finger will be randomly assigned to treatment with PRP, corticosteroid, or normal saline injection. The primary outcome is Patient-Rated Wrist Evaluation and symptom resolution. Secondary outcomes include Quick-Disabilities of the Arm, Shoulder and Hand; pain; grip strength; finger active range of motion; and complications. Appropriate statistical methods will be applied. DISCUSSION: We present a novel RCT study design on the use of PRP for the treatment of trigger finger compared to corticosteroid and normal saline injection. The results of the trial will indicate if PRP is appropriate for the treatment of trigger finger. TRIAL REGISTRATION: ClinicalTrials.gov NCT04167098 . Registered on November 18, 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Aspinen S, Nordback PH, Anttila T, et al. Platelet-rich plasma versus corticosteroid injection for treatment of trigger finger: study protocol for a prospective randomized triple-blind placebo-controlled trial. Trials. 2020. PMID: 33246497. doi:10.1186/s13063-020-04907-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。